The Board of Pharmacy announced effective September 3, online renewals were available in your online profile by clicking the “Renewal” button located near the top of the page. Once you have successfully renewed, your updated license / permit will be available in your online profile. Renewal applications submitted after November 7, 2024, will be assessed as a late renewal penalty.

For licensee renewals, please ensure you have completed all continuing education (“CE”) requirements before submitting your renewal application. You may review the 2024 CE requirements.

When submitting your renewal application, please use a standard desktop or laptop computer running a current version of Google Chrome; the online profile may not be compatible with mobile devices.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Gov. Katie Hobbs (D) signed SB 1211 (Chapter 232), legislation allowing pharmacists to dispense naloxone hydrochloride, or any other opioid antagonist approved by the FDA without a signed prescription and removing the requirement that the Board of Pharmacy establish protocols for the dispensing of naloxone hydrochloride and other opioid antagonists.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Gov. Katie Hobbs signed SB 1211 (Chapter 232), legislation allowing pharmacists to dispense naloxone hydrochloride or any other opioid antagonist approved by the US Food and Drug Administration without a signed prescription; removing the requirement that a pharmacist who dispenses naloxone hydrochloride or another opioid antagonist report outlined prescription information, including the name, strength, quantity, dosage and national drug code number of the drug; and removing the requirement that the Board of Pharmacy establish protocols for the dispensing of naloxone hydrochloride and other opioid antagonists. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy will meet on June 19 and 20. Visit the Board’s website in advance to review the agenda.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Gov. Katie Hobbs (D) issued Executive Order 2024-03 “Protecting Reproductive Freedom Through Increased Access to Contraception.”

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted its recent newsletter.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Gov. Katie Hobbs (D) signed HB (House Bill) 2582 (Chapter 123), legislation permitting pharmacists to enter into collaborative practice agreements with a state-licensed certified nurse midwife or a physician assistant.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

On March 29, Gov. Katie Hobbs (D) signed SB 1165 (Chapter 51), legislation outlining specified provisions an auditing entity must comply with when conducting a wholesale invoice audit and prohibits an auditing entity from retroactively reducing the amount of a claim unless specified criteria apply.  

Also in Arizona, on April 2, Gov. Katie Hobbs (D) signed SB 1021, legislation removing the requirement that health professional groups proposing to increase the scope of practice of a state-regulated health profession must complete a statutory sunrise review. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

On March 6, upon reconsideration, the Senate failed to pass SB 1085 by one vote. This bill would have authorized pharmacists to test and initiate treatment for conditions such as influenza, COVID, strep and other respiratory illnesses and to delegate the administrative and technical tasks of performing a test to a trained member of the pharmacy staff who is under the supervision of the pharmacist. 

Also in Arizona, this week, the Department of Health Services (ADHS) launched a naloxone campaign aimed at combating the state’s opioid overdose crisis. This multi-media campaign features stories from a diverse group of Arizonans whose lives were impacted by naloxone, connects those with substance use disorder to support resources, and demonstrates how to use naloxone to save lives. The FDA-approved injectable and nasal spray formulations are available over the counter, at pharmacies, community-based distribution programs, and through local health departments, making it possible for the public to also utilize naloxone to save lives. The ADHS encourages individuals to get it without a prescription at your local pharmacy.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.